Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India.
Earnings for Neuland Laboratories Limited (NEULANDLAB.NS)
Earnings in 2023 (TTM): $47.56 M
According to Neuland Laboratories Limited's latest financial reports the company's current earnings (TTM) are $47.56 M. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Neuland Laboratories Limited
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $47.56 M | $35.55 M |
| 2022 | $25.56 M | $19.37 M |
| 2021 | $9.73 M | $7.56 M |
| 2020 | $12.48 M | $9.55 M |
| 2019 | $6.27 M | $1.92 M |
| 2018 | $2.41 M | $1.95 M |
| 2017 | $1.65 M | $1.43 M |
| 2016 | $5.85 M | $3.89 M |
| 2015 | $4.98 M | $3.24 M |
| 2014 | $2.93 M | $1.89 M |
| 2013 | $4.09 M | $3.18 M |
| 2012 | $2.24 M | $1.64 M |
| 2011 | $98.45 K | $303.42 K |
| 2010 | $585.04 K | $626.63 K |
| 2009 | $-1,162,740 | $-818,088 |
| 2008 | $1.73 M | $1.41 M |